CYTOAURORA BIOTECHNOLOGIES, INC.
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
The blood detection chip developed by CytoAurora is based on Taiwan's semiconductor technology, combined with self-developed artificial intelligence software, and integrated molecular pathology technology to develop a world-leading cancer detection equipment, and has received full support from Taiwan's National Research Institute At present, it has cooperated with many major hospitals in Taiwan in the clinical IRB program, and the effect has been affirmed.
Founded Year
2015
Unified Business No.
42579799
Status
Active
Number of Employees
0
Total Paid-in
Capital
88,018,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Established in 2015, CytoAurora Biotechnology actively promotes cross-field integration, hoping to introduce the biotechnology and medical industry with the advantages of Taiwan's semiconductor and electronics industries, and is committed to the research and development of innovative cell biotechnology and equipment, which can be applied to gene and protein research. Aim at the research and development in the field of precision medicine, provide more accurate medical services, and give back to the society.
